Read more about the article Ovarian Cancer – Mirvetuximab Soravtansine Yields Benefit
סרטן השחלות- Mirvetuximab Soravtansine מניב תועלת

Ovarian Cancer – Mirvetuximab Soravtansine Yields Benefit

Background Patients with platinum-resistant ovarian cancer have limited therapeutic options available to them. Treatment is largely comprised of chemotherapy, which is known to have limited efficacy where just 4% and…

Continue ReadingOvarian Cancer – Mirvetuximab Soravtansine Yields Benefit
Read more about the article Lung cancer – Toripalimab Plus Chemo is Better than Chemo Alone
סרטן ריאה – טוריפאלימאב עם כימו' עדיף על כימו' לבד

Lung cancer – Toripalimab Plus Chemo is Better than Chemo Alone

Background According to data from the CHOICE-1 trial, Toripalimab (anti–PD-1) in combination with chemotherapy showed significant improvement in the length of time until progression of the disease (Also called, Progression-Free…

Continue ReadingLung cancer – Toripalimab Plus Chemo is Better than Chemo Alone
Read more about the article Cervical Cancer – New drug combination: Balstilimab Plus Zalifrelimab
Cervical Cancer - New drug combination: Balstilimab Plus Zalifrelimab

Cervical Cancer – New drug combination: Balstilimab Plus Zalifrelimab

Overview Advanced cases of cervical cancer pose a challenge for physicians to treat. Once the cancer cells have spread to other tissues, procedures such as surgery and curative radiation therapy…

Continue ReadingCervical Cancer – New drug combination: Balstilimab Plus Zalifrelimab